NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









NeuraLight

NeuraLight

Private
Tel AvivHealthcare & Life Scienceshttps://www.neuralight.ai/

Last Round

Series A

May 24, 2022

Total Funding Raised

$30.5M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

NeuraLight is a digital health company that provides an AI-driven platform designed to assist patients with neurological disorders by utilizing a proprietary oculometric database for enhanced diagnosis and monitoring through standard smartphones or webcams.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Biotechnology, Medical AI, Healthcare Analytics, Computer Vision

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

digital biomarkersoculometric dataeye-trackingclinical trial endpointsneurological evaluationdigital healthneurodegenerative diseasecomputer visionmedical AIsmartphone diagnosticsremote patient monitoringRPMclinical research organizationCROhealthtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NeuraLight Comparables

Compare NeuraLight with similar companies based on industry and business-model similarity.

NeuraLight comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Altoida, Inc.
83%
Innodem Neurosciences
82%
Koneksa Health
78%

NeuraLight Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMay 24, 2022
SeedOct 29, 2021

Key People

Founding team and executive leadership

Edmund Ben-Ami

Co-Founder CEO

Founding Team

NeuraLight Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 26, 2026

    Professor Olivier Rascol appointed Chair of the Scientific Advisory Board.

  • Oct 27, 2025

    Selected as a finalist for the Prix Galien USA Award in Digital Health.

NeuraLight Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

NeuraLight Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about NeuraLight's valuation, stock price, and market status.

Firmographic Details

HeadquartersTel Aviv
Employee Range29
Year Founded2021
Last FundingMay 24, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.